Effect of the anti-oxidant probucol on soluble thrombomodulin (sTM) in hypercholesterolemic rabbits

Int J Cardiol. 2008 Jan 11;123(2):180-2. doi: 10.1016/j.ijcard.2006.11.111. Epub 2007 Feb 8.

Abstract

Introduction: Thrombomodulin is an integral endothelial cell membrane protein, exists not only on the surface of endothelial cells but also as soluble fragments circulating in plasma. Probucol has anti-oxidant properties as well as cholesterol-lowering effects and may affect soluble thrombomodulin (sTM).

Methods: Sixteen rabbits fed with high-cholesterol diet for 8 weeks were randomly divided into two groups: (1) high-cholesterol group (n=8): maintained high-cholesterol diet; (2) probucol group (n=8): the same diet plus probucol for 6 weeks. Control group (n=8) was fed with normal diet for 14 weeks. The levels of sTM and oxidized low-density lipoprotein (OX-LDL) were measured using ELISA.

Results: There were atherosclerotic lesions in aortas and intimal thickness significantly increased in high-cholesterol group. Probucol significantly reduced the lesion area (56.4%+/-9.8% vs 82.5%+/-10.5%) and decreased the intimal thickness (44.65+/-7.25 mum vs 72.21+/-8.32) as compared with high-cholesterol group, all P<0.01. Probucol decreased the level of OX-LDL and sTM as compared with high-cholesterol group, all P<0.05.

Conclusions: Probucol retarded the plaques formation may relate to decrease plasma OX-LDL and sTM concentration, which may improve endothelial function in hypercholesterolemic rabbit.

Publication types

  • Letter

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Anticholesteremic Agents / therapeutic use
  • Antioxidants / pharmacology*
  • Antioxidants / therapeutic use
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / drug therapy
  • Male
  • Probucol / pharmacology*
  • Probucol / therapeutic use
  • Rabbits
  • Thrombomodulin / drug effects*

Substances

  • Anticholesteremic Agents
  • Antioxidants
  • Thrombomodulin
  • Probucol